News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotech Firm Galapagos Genomics NV To Raise Up To 40 Million Euro In Brussels-Amsterdam IPO



10/19/2005 5:12:43 PM

AMSTERDAM (AFX) - Galapagos NV said it plans to raise up to 40.25 mln eur in an initial public offering on the Brussels and Amsterdam stock exchanges. Subscription for the shares, which are expected to sell for 8-10 eur each, will start on Monday and run until April 28. KBC Securities and Kempen & Co are joint lead managers and bookrunners. The offering includes 35 mln eur in new shares plus 82,562 shares from the exercise of warrants, as well as an over-allotment option of new shares worth another 5.25 mln eur.

Read at Yahoo Finance


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES